SCHEMBL17593181

SCHEMBL17593181

O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2)cc1)c1ccc(Cl)cc1

nearest known ligand 0.92

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.92
MEN1 O00255 4/20 0.92
NAMPT P43490 1/20 0.73
USP2 O75604 1/20 0.71
ALDH1A1 P00352 1/20 0.71
PKM P14618 1/20 0.71
SMN1; SMN2 Q16637 1/20 0.71
GPR27 Q9NS67 8/20 0.70
AVPR2 P30518 1/20 0.69
EGFR P00533 1/20 0.68
FGFR1 P11362 1/20 0.68
KDR P35968 1/20 0.68
GBA1 P04062 1/20 0.67
PSMD14 O00487 1/20 0.67
FGB P02675 1/20 0.67
POLB P06746 1/20 0.67
MAPT P10636 1/20 0.67
CYP2C9 P11712 1/20 0.67
CYP2C19 P33261 1/20 0.67
CACNA1B Q00975 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12010895 0.91 KMT2A (0.83) KMT2AMEN1USP2ALDH1A1PKM
SCHEMBL12010897 0.90 KMT2A (0.91) KMT2AMEN1USP2ALDH1A1PKM
SCHEMBL17066584 0.87 GPR55 (0.80) KMT2AMEN1NAMPTALDH1A1SMN1; SMN2
SCHEMBL12010900 0.87 KMT2A (0.81) KMT2AMEN1USP2ALDH1A1PKM
SCHEMBL30926705 0.86 KMT2A (0.70) KMT2AMEN1NAMPTUSP2ALDH1A1
SCHEMBL27179849 0.86 KMT2A (0.70) KMT2AMEN1NAMPTUSP2ALDH1A1
SCHEMBL2561573 0.85 KMT2A (1.00) KMT2AMEN1USP2ALDH1A1PKM
SCHEMBL27180941 0.85 KMT2A (0.67) KMT2AMEN1NAMPTALDH1A1SMN1; SMN2
SCHEMBL27180069 0.84 PPIA (0.73) KMT2AMEN1NAMPTALDH1A1SMN1; SMN2
SCHEMBL27181616 0.84 PPIA (0.73) KMT2AMEN1NAMPTALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016040449-A1 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF RAZE THERAPEUTICS, INC. (US) 2016-03-17 WO disclosed